MedPath

A Study on Aruvadha chooranam in the management of Kaleeral noi(Non- Alcoholic fatty liver disease)

Phase 2
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2023/08/056413
Lead Sponsor
ational Institute of siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with any of the symptoms of NAFLD/YAGUDHAM such as pain or discomfort in the right upper quadrant/epigastric region of the abdomen, nausea, vomting, indigestion, anorexia, early satiety, fatigue, bloating and distension.

2.Patients with USG findings suggestive of fatty liver grades 1,2,3 showing fatty infiltration of the liver

Exclusion Criteria

1.Patients who are known to consume alcohol

2.Patients with chronic kidney disease, cardiovascular diseases

3.Patients with known liver diseases such as viral hepatitis, autoimmune disorders, biliary disorders, liver abscess, liver cirrhosis and malignancy

4.Pregnancy associated with liver disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in grades of fatty liver in USG abdomen scan will be assessed before & after treatmentTimepoint: 18 months
Secondary Outcome Measures
NameTimeMethod
1 Reduction in values of lipid profile, & LFT will be assessed before & after treatment <br/ ><br>2 Anthropometric changes such as waist circumference & BMI wibb be assessed before and after treatmentTimepoint: 18 months
© Copyright 2025. All Rights Reserved by MedPath